Lv7
4360 积分 2026-04-23 加入
Antitumor Cytotoxic Activity Retained in Tolerized T Cells Following Daily Dose Escalation of a T‐Cell Engager in Cynomolgus Monkeys to Mitigate Cytokine Release Syndrome
3小时前
已完结
Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib
3天前
已完结
Population Pharmacokinetics of the BTK Inhibitor Acalabrutinib and its Active Metabolite in Healthy Volunteers and Patients with B-Cell Malignancies
3天前
已完结
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
6天前
已完结
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy
6天前
已完结
Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
6天前
已完结
Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
6天前
已完结
Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib
6天前
已完结
Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy
6天前
已完结
Membranous nephropathy
8天前
已完结
皖公网安备34019202002308
